1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HAUS5 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA CTC1 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA ZBTB5 CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA RP3-403A15.5 CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA ZIK1 CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA HNRNPA0 CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA BRSK1 CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA ATL1 CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA ZCCHC11 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA NTNG2 CTRPv2 pan-cancer AAC 0.16 3e-07
Download CSV